Welcome to Paid Research Studies




  • Conditions:   Lobular Breast Carcinoma;   Gastric Cancer
    Interventions:   Drug: Crizotinib Oral Capsule [Xalkori];   Drug: Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]
    Sponsors:   Royal Marsden NHS Foundation Trust;   Pfizer;   Breast Cancer Now
    Not yet recruiting

  • Condition:   Breast Cancer
    Interventions:   Combination Product: LightPath® Imaging System and 68Ga-RM2;   Drug: 68Ga-RM2
    Sponsor:   Lightpoint Medical Limited
    Not yet recruiting

  • Condition:   Breast Cancer
    Intervention:   Other: Collection of blood
    Sponsors:   Sanford Health;   Inanovate
    Recruiting

  • Condition:   Breast Cancer
    Interventions:   Other: Under- or overdiagnosed cancer;   Other: Screening
    Sponsors:   Cancer Registry of Norway;   Extrastiftelsen
    Active, not recruiting

  • Conditions:   Breast Cancer Female;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer;   Ductal Carcinoma in Situ;   Ductal Breast Carcinoma;   Lobular Breast Carcinoma
    Interventions:   Other: Breast reconstruction decision aid;   Other: Educational website
    Sponsors:   University of Texas at Austin;   Ohio State University;   Washington University School of Medicine
    Recruiting

  • Conditions:   Breast Fibroadenoma;   Atypical Ductal Hyperplasia;   Atypical Lobular Hyperplasia;   Lobular Carcinoma in Situ;   Flat Epithelial Atypia;   Phyllodes; Fibroadenoma;   Phyllodes Breast Tumor;   Radial Scar;   Breast Papilloma;   Complex Sclerosing Papillary Lesion of the Breast
    Interventions:   Procedure: Vacuum-assisted percutaneous excision;   Procedure: Open surgical excision
    Sponsor:   Lawson Health Research Institute
    Not yet recruiting

  • Condition:   Ductal Carcinomas
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting